{
    "code": "52026475",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026475",
    "time": "2023-09-14 19:53:11",
    "許可證字號": "衛部藥輸字第026475號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/01\/08",
    "發證\/登錄日期": "104\/01\/08",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202647500",
    "中文品名": "福適佳膜衣錠5毫克",
    "英文品名": "Forxiga Film-coated Tablets 5mg",
    "適應症": "1.第二型糖尿病：\r\n(1)血糖控制：配合飲食和運動，以改善第二型糖尿病成人病人的血糖控制。\r\n(2)預防心血管事件：用於具第二型糖尿病且已有心血管疾病 (CVD) 或多重心血管風險因子的成人病人時，可降低心衰竭住院的風險。\r\n(3)預防腎臟病：降低慢性腎臟病 (CKD) 新發生或惡化的風險。\r\n2.慢性腎臟病：\r\n用於治療有惡化風險之慢性腎臟病的成人病人時，可降低持續性腎絲球過濾率 (eGFR) 下降、末期腎病 (ESKD)、心衰竭住院和心血管死亡的風險。\r\n3.心衰竭：\r\n用於心衰竭的成人病人時，可降低心血管死亡、心衰竭住院和心衰竭緊急就醫的風險。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000錠Alu\/Alu blister鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "109\/01\/08",
    "主成分略述": "Dapagliflozin propanediol monohydrate",
    "限制項目": "02輸　入 51免除銜接性臨床試驗",
    "申請商名稱": "臺灣阿斯特捷利康股份有限公司",
    "申請商地址": "台北市大安區敦化南路二段207號21樓",
    "主製造廠": [
        {
            "製造廠名稱": "AstraZeneca Pharmaceuticals LP",
            "製造廠廠址": "4601 HIGHWAY 62 EAST, MOUNT VERNON, INDIANA 47620 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "ASTRAZENECA UK LIMITED",
            "製造廠廠址": "SILK ROAD BUSINESS PARK,MACCLESFIELD,CHESHIRE,SK10 2NA",
            "製造廠公司地址": "ALDERLEY PARK MACCLESFIELD CHESHIRE SK 10 4TF",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6820602210",
            "成分名稱": "Dapagliflozin propanediol monohydrate",
            "含量描述": "(=Dapagliflozin 5mg)",
            "含量": "6.1500000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "01. Forxiga Film Coated Tablets - 中文仿單-110-08-20.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026475&Seq=008&Type=9"
        },
        {
            "title": "026475 - Forxiga Film-coated Tablets 5mg - 鋁箔-108-03-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026475&Seq=005&Type=8"
        },
        {
            "title": "026475 - Forxiga Film-coated Tablets 5mg - 外盒-108-03-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026475&Seq=004&Type=8"
        },
        {
            "title": "020264750003-104-01-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026475&Seq=003&Type=8"
        }
    ]
}